Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798185 · ClinicalTrials.gov registry record
The DIAGNOSE-CTE Research Project
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 240
- Enrollment target
NCT02798185 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 240 participants.
The verdict
NCT02798185 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in the brain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2016-08 |
| Est. Completion | 2023-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02798185
The ClinicalTrials.gov registry entry for NCT02798185 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02798185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02798185 about?
NCT02798185 is a clinical study titled "The DIAGNOSE-CTE Research Project". This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in th...
What is the current status of trial NCT02798185?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2016-08. Estimated completion is 2023-11-15.
Who is sponsoring clinical trial NCT02798185?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.